Denver-Intravitreal bevacizumab (Avastin, Genentech) proved to be a successful treatment in a patient with neovascular glaucoma.
Elkin: Talking about the importance of pediatric eye health and safety
Rachitskaya: Archway found incidence of retinal fluid at Week 96 was generally comparable across treatment arms
Emanuel: Educating patients diagnosed with cataracts is key for physicians
